Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7255 results

Sort By:

Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers

Study ID: NCT06085716
Start Date: 2024-02-16
End Date: 2029-08-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

240

Intervention / Treatment

Psychoeducational Intervention

Open Label Placebo

Psychoeducational Intervention+Placebo

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Food: A Three-Arm Study Examining Food Insecurity Interventions

Study ID: NCT01603316
Start Date: 2012-05-08
End Date: 2026-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

668

Intervention / Treatment

surveys

Focus groups

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

Study ID: NCT05142696
Start Date: 2022-07-13
End Date: 2029-03-23
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

[177Lu]Lu-DOTA-TATE

Atezolizumab

[68Ga]Ga-DOTA-TATE

Carboplatin

Etoposide

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Neoadjuvant Targeting of Myeloid Cell Populations in Combination With Nivolumab in Head & Neck Ca

Study ID: NCT04848116
Start Date: 2021-04-24
End Date: 2026-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

Nivolumab

Are the fifties

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Apixaban in Thrombocytopenia

Study ID: NCT06886516
Start Date: 2025-02-28
End Date: 2028-07-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

30

Intervention / Treatment

Apixaban

Sponsor

Rushad Patell

Source: clinicaltrials.gov

Share:
Add to list

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Study ID: NCT07052916
Start Date: 2025-06-27
End Date: 2026-12-27
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Music Therapy/MT

Therapist-Attention Music Education/TAME Control

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique

Study ID: NCT05359016
Start Date: 2020-12-22
End Date: 2027-02-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

14600

Intervention / Treatment

HPV testing of women for cervical cancer screening

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Study ID: NCT06246916
Start Date: 2024-09-09
End Date: 2033-07-10
Study Type

Interventional

Study Phase

Phase3

No. of Participants

560

Intervention / Treatment

Familimab

Cemiplimab

relatlimab+nivolumab

Sponsor

Regeneron Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

A Study of Avutometinib and Defactinib in People With Thyroid Cancer

Study ID: NCT06007924
Start Date: 2023-08-16
End Date: 2027-08-16
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Umutine

Defactinib

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach

Study ID: NCT05829824
Start Date: 2023-11-27
End Date: 2025-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

CareConnect

AutoReach

Biospecimen samples

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list